Skip to main content
Himatsingka Seide Ltd. logo

Himatsingka Seide Ltd. — Investor Relations & Filings

Ticker · HIMATSEIDE ISIN · INE049A01027 LEI · 335800QS6H3JJAKAWA43 BSE.NS Manufacturing
Open in API
Filings indexed 1,435 across all filing types
Latest filing 2025-11-11 Regulatory Filings
Country IN India
Listing BSE.NS HIMATSEIDE

About Himatsingka Seide Ltd.

https://www.himatsingka.com/

Himatsingka Seide Ltd. is a vertically integrated home textile major focused on the design, development, manufacturing, and distribution of premium home textile products. The company operates a global supply chain, specializing in bedding, bath, and drapery and upholstery fabrics. Its product portfolio includes a mix of licensed global brands, private labels, and owned brands, catering primarily to the luxury and premium segments of the market. With large-scale manufacturing facilities, the company maintains control over the entire production process, from spinning and weaving to finishing and distribution. Himatsingka Seide serves a diverse international clientele across North America, Europe, and Asia, leveraging its design capabilities and distribution network to maintain a significant presence in the global home textiles market.

Recent filings

Filing Released Lang Actions
In accordance with the captioned regulation, we hereby inform you of the schedule of Analyst/ Institutional Investor meet as under: Date and Time: November 14, 2025; 2:00 p.m. to ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of the schedule for an Analyst/Institutional Investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content is about announcing the schedule of an investor meeting and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report contents included. The document length is short (1805 characters), and it serves as an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the schedule of an Analyst/Institutional Investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 related to disclosure of events or information. The content is an announcement of a scheduled investor meeting, explicitly stating no unpublished price sensitive information will be shared. The document length is short (1805 characters), and it does not contain any financial data, report, or detailed presentation. It is an informational notice about an upcoming event rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an invitation to an earnings call scheduled for November 13, 2025, to discuss the unaudited financial results for the quarter and half year ended September 30, 2025. It includes details about the call, participants, and dial-in information. There are no actual financial statements or substantive financial data presented in the document. It is a notice about the upcoming earnings call rather than the earnings release itself or a transcript. Therefore, the document fits the category of a Call Transcript (CT) invitation or announcement. Since it is an invitation to the earnings call, the best fitting category is Call Transcript (CT).
2025-11-07 English
Enclosed is copy of invitation for Q2 FY26 Earnings Call for Analysts and Investors, scheduled to be held on Thursday, November 13, 2025, at 16:00 hrs IST by way of group call.
Call Transcript Classification · 80% confidence The document is an invitation to an earnings call scheduled for November 13, 2025, to discuss the unaudited financial results for the quarter and half year ended September 30, 2025. It references the upcoming board meeting to consider these results but does not contain any actual financial data or results itself. The document is short (3125 characters) and serves as a notice or invitation rather than a report or transcript. Therefore, it is best classified as a Call Transcript (CT) invitation notice, but since it is only an invite and not the transcript, the closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement. However, given the specific nature of the document as an earnings call invite, the best classification is Call Transcript (CT) with moderate confidence, as it is related to the call but not the transcript itself.
2025-11-07 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-04 English
Himatsingka Seide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of a scheduled Board of Directors meeting to consider and approve unaudited financial results for the quarter and half year ended September 30, 2025. It references compliance with SEBI regulations and insider trading window closure. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a prior intimation or announcement of a board meeting and upcoming financial results, not the financial report or earnings release itself. The document length is short (1807 characters), and it serves as a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication rather than a financial report or earnings release.
2025-11-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.